Lysosomal Storage Diseases clinical trials at University of California Health
2 in progress, 0 open to eligible people
Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the safety, tolerability, and efficacy of a single intravenous infusion of SPK-3006 in adults with clinically moderate, late-onset Pompe disease receiving enzyme replacement therapy (ERT). Participants will be treated in sequential, dose-level cohorts.
at UC Irvine
Stem Cell Gene Therapy for Cystinosis
Sorry, in progress, not accepting new patients
This study is a Phase 1/2 clinical trial that will assess the safety and efficacy of enriched gene-corrected hematopoietic stem cells isolated from patients affected with cystinosis. (Investigational Product: CTNS-RD-04 or CTNS-RD-04-LB, where the suffix "-LB" stands for LentiBOOST)
at UCSD
Our lead scientists for Lysosomal Storage Diseases research studies include Stephanie Cherqui, Ph.D. Tahseen Mozaffar, MD.
Last updated: